SCHEMBL7230890

SCHEMBL7230890

CC(C)(C)[Si](C)(C)OCc1cccnc1-c1cccc(N)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 6/20 0.40
NPC1 O15118 1/20 0.38
AXL P30530 2/20 0.36
MKNK2 Q9HBH9 2/20 0.36
MEN1 O00255 1/20 0.36
PSIP1 O75475 1/20 0.36
MKNK1 Q9BUB5 1/20 0.36
KCNA5 P22460 6/20 0.36
KCNH2 Q12809 2/20 0.36
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
GFER P55789 1/20 0.34
MAP4K1 Q92918 1/20 0.34
BACE1 P56817 1/20 0.33
PLK4 O00444 1/20 0.33
EGFR P00533 1/20 0.33
ROS1 P08922 1/20 0.33
PIM1 P11309 1/20 0.33
FLT3 P36888 1/20 0.33
FRK P42685 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7232523 0.80 PDE4D (0.50) NPC1MEN1
SCHEMBL7230492 0.78 MAP4K4 (0.43) MAP4K4NPC1AXLMKNK2MEN1
SCHEMBL5465604 0.77 BACE1 (0.39) NPC1ALDH1A1BACE1
SCHEMBL21805721 0.75 MAP4K4 (0.51) MAP4K4NPC1AXLMKNK2MEN1
SCHEMBL30087906 0.75 MAP4K4 (0.51) MAP4K4NPC1AXLMKNK2MEN1
SCHEMBL7846042 0.73 CYP17A1 (0.34) NPC1ALDH1A1BACE1
SCHEMBL7846039 0.73 HRH2 (0.36) ALDH1A1BACE1
SCHEMBL7237052 0.73 NPFFR1 (0.37) ALDH1A1BACE1
SCHEMBL15389825 0.73 BACE1 (0.42) BACE1
SCHEMBL2084571 0.72 BACE1 (0.40) MEN1BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6521643-B1 Prevention and/or treatment of nitric oxide synthasey medi-ated diseases such as adult respiratory distress syndrome, myocarditis, synovitis, septic shock, diabetes, ulcerative colitis, cerebral infarction, osteoarthritis FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-02-18 US disclosed
EP-1157022-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-28 EP disclosed
WO-2000049015-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-08-24 WO disclosed